Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic

Chia Siang Kow; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan

doi:10.1016/j.medcli.2022.05.016

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e61
Number of pages	1
Journal	Medicina Clinica
Volume	159
Issue number	9
Early online date	20 Jul 2022
DOIs	https://doi.org/10.1016/j.medcli.2022.05.016
Publication status	Published - 11 Nov 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.medcli.2022.05.016Licence: Unspecified

Cite this

@article{57b31c89496b4c259b027e6e832c7286,

title = "Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic",

keywords = "Direct oral anticoagulants (DOAC), atrial fibrillation, COVID-19 pandemic",

author = "Kow, {Chia Siang} and Ramachandram, {Dinesh Sangarran} and Hasan, {Syed Shahzad}",

year = "2022",

month = nov,

day = "11",

doi = "10.1016/j.medcli.2022.05.016",

language = "English",

volume = "159",

pages = "e61",

journal = "Medicina Clinica",

issn = "0025-7753",

publisher = "Ediciones Doyma, S.L.",

number = "9",

}

TY - JOUR

T1 - Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic

AU - Kow, Chia Siang

AU - Ramachandram, Dinesh Sangarran

AU - Hasan, Syed Shahzad

PY - 2022/11/11

Y1 - 2022/11/11

KW - Direct oral anticoagulants (DOAC)

KW - atrial fibrillation

KW - COVID-19 pandemic

UR - http://www.scopus.com/inward/record.url?scp=85135859543&partnerID=8YFLogxK

U2 - 10.1016/j.medcli.2022.05.016

DO - 10.1016/j.medcli.2022.05.016

M3 - Letter

C2 - 35933189

AN - SCOPUS:85135859543

VL - 159

SP - e61

JO - Medicina Clinica

JF - Medicina Clinica

SN - 0025-7753

IS - 9

ER -

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic

UN SDGs

Access to Document

Other files and links

Cite this